109221 ⎘
Applications; Uses Special therapeutic applications
Selective reactivation of genes on the inactive X chromosome
#1502Method for regulating cell proliferation
#1503Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#1504Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
#1505GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HEAMOPHILUS INFLUENZAE
#1506INHIBITORS OF ALPHA6 INTEGRIN/E-CADHERIN COMPLEX
#1507Compositions for the delivery of RNA and drugs into cells
#1508Compositions and methods for detecting and treating colorectal cancer
#1509Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#1510INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN PCAF FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES OR FOR THE TREATMENT OF CANCER
#1511Methods of treatment using TLR7 and/or TLR9 inhibitors
#1512CTLA-4 aptamer siRNA species
#1513Double-stranded oligonucleotide molecules to P53 and methods of use thereof
#1514Exosomes and micro-ribonucleic acids for tissue regeneration
#1515Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA
#1516Structurally designed shRNAs
#1517Agent for treating cancer
#1518Modulation of UBE3A-ATS expression
#1519Bacteria mediated gene silencing
#1520MODULATION OF APOLIPOPROTEIN (a) EXPRESSION
#1521Use of nanodiamonds for generating free radicals for therapeutic purposes under radiation
#1522Use of SIRT7 as novel cancer therapy target and method for treating cancer using the same
#1523Methods for treating hypercholesterolemia
#1524RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#1525METHODS AND COMPOSITIONS RELATED TO THE SMCHD1 GENE
#1526Generation of human induced pluripotent stem cells using nucleic acid sequences that inhibit Δ-NP63 and DGCR8
#1527Chemical modification of short small hairpin RNAs for inhibition of gene expression
#1528Modulation of TLR4-signaling pathway
#1529MCP-1 Binding Nucleic Acids and Use Thereof
#1530Methods of treating and diagnosing diseases using agents that regulate the alternative splicing pathway
#1531Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
#1532STABILIZED APTAMERS TO PLATELET DERIVED GROWTH FACTOR AND THEIR USE AS ONCOLOGY THERAPEUTICS
#1533Micro-RNA inhibitors and their uses in disease
#1534Modified small activating RNA molecules and methods of use
#1535RNA products and uses thereof
#1536METHOD OF THERAPY AND DIAGNOSIS OF ENDOTHELIAL DYSFUNCTION
#1537Inhibition of DNA2 in fanconi anemia
#1538Compositions and methods for inhibiting expression of the ALAS1 gene
#1539Multi-targeting short interfering RNAs
#1540MicroRNA compounds and methods for modulating miR-122
#1541RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
#1542OLIGONUCLEOTIDE COMPOSITIONS WITH ENHANCED EFFICIENCY
#1543Compositions and methods for gene silencing
#1544COMPOSITIONS AND METHODS FOR MODULATING MITOCHONDRIAL PYRUVATE CARRIER ACTIVITY
#1545Methods of Treating Hepatitis C Virus Infection
#1546Targeting micrornas for the treatment of fibrosis
#1547Genetic correction of mutated genes
#1548Methods and pharmaceutical compositions for the treatment of hypertension
#1549Functionalized fluorine containing phthalocyanine molecules
#1550Composition for prophylaxis or treatment of vascular or cardiac valvular calcification comprising dipeptidyl peptidase-4 inhibitor
#1551MEDICINAL COMPOSITION FOR TREATING INFARCTION
#1552Methods and compositions for treatment of a genetic condition
#1553Oligomers
#1554Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
#1555Method of enhancing the efficacy of anti-hepatocyte growth factor receptor breast cancer therapy by administering an inhibitor of mena
#1556Compositions for Inhibiting Gene Expression and Uses Thereof
#1557Nucleic acids specifically binding CGRP
#1558Compositions and methods for treatment of ovarian cancer
#1559BIOMARKER, USES THEREOF AND THERAPY
#1560Methods and compositions for neuroprotection
#1561Vitamin B6-coupled poly(ester amine) as gene carrier and application in cancer gene therapy
#1562BACTERIAL MEDIATED THF ALPHA GENE SILENCING
#1563Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disorders
#1564Embryonic stem cell specific microRNAs promote induced pluripotency
#1565Fluoride-responsive riboswitches, fluoride transporters, and methods of use
#1566Compositions and methods for the modulation of DNA damage responses using BAL1 and BBAP
#1567MODULATION OF BREAST CANCER GROWTH BY MODULATION OF XBP1 ACTIVITY
#1568CELL ADHESION INHIBITOR, CELL PROLIFERATION INHIBITOR, AND METHOD AND KIT FOR EXAMINING CANCER
#1569Double-stranded and single-stranded RNA molecules with 5′ Triphosphates and their use for inducing interferon
#1570NUCLEIC ACID MOLECULE FOR INHIBITING ACTIVITY OF RNAI MOLECULE
#1571METHODS AND COMPOSITIONS FOR TREATING INSECTS
#1572MicroRNAs for cardiac regeneration through induction of cardiac myocyte proliferation
#1573iRNA Agents Targeting VEGF
#1574Compositions and methods to promote erythropoiesis
#1575Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression
#1576PULMONARY HYPERTENSION
#1577Compositions and Methods for Suppressing Gene Expression of p53 and Clusterin
#1578Use of microrna molecules to influence skin pigmentation
#1579Aptamer which selectively binds to ERBB2 receptor and uses thereof
#1580ADAM12 inhibitors and their use against inflammation-induced fibrosis
#1581Methods for diagnosing and treating learning or mental disorders
#1582High-efficiency nanoparticle-type double-helical oligo-RNA structure and method for preparing same
#1583Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer
#1584Novel shRNA Molecules and Methods of Use Thereof
#1585Methods and compositions involving miRNA and miRNA inhibitor molecules
#1586OSTEOPONTIN ISOFORM A INHIBITORS AND METHODS OF USE
#1587Transcriptional repression leading to parkinson's disease
#1588MODULATION OF RNA BY REPEAT TARGETING
#1589INHIBITION OF PATTERN RECOGNITION RECEPTORS IN PANCREATIC CANCER TREATMENT USING TLR INHIBITORS
#1590Retinaldehyde mimetics and inhibitors of retinaldehyde dehydrogenase I in the treatment of disorders
#1591BIOMARKERS OF MIR-34 ACTIVITY
#1592DESIGN OF NUCLEIC ACID BINDING MOLECULES WITH NON-WATSON CRICK AND NON-CANONICAL PAIRING BASED ON ARTIFICIAL MUTATION CONSENSUS SEQUENCES TO COUNTER ESCAPE MUTATIONS
#1593TREATMENT OF UTERINE LEIOMYOMATA
#1594Pharmaceutical Composition Comprising miRNA-100 And Its Use In The Modulation of Blood Vessel Growth and Endothelial Inflammation
#1595Agonists and antagonists of toll-like receptor (TLR) 13
#1596Treatment of vasculoproliferative conditions with Lrg1 antagonists
#1597METHODS AND COMPOSITIONS TO DETECT THE LEVEL OF LYSOSOMAL EXOCYTOSIS ACTIVITY AND METHODS OF USE
#1598Compositions for RNA interference and methods of use thereof
#1599SINGLE-STRANDED ANTIMICROBIAL OLIGONUCLEOTIDES AND USES THEREOF
#1600Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2
#1601Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expression
#1602Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#1603PREPARATION OF PNA-6-AMINOGLUCOSAMINE CONJUGATES AS ANTIVIRAL AGENTS
#1604RNA interference for the treatment of gain-of-function disorders
#1605Methods and compositions for the treatment of cancer
#1606MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#1607Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#1608Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease
#1609RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
#1610RNAi-mediated inhibition of tumor necrosis factor α-related conditions
#1611Metabolic gene mesenchymal signatures and uses thereof
#1612RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
#1613COMPOSITIONS AND METHODS FOR TREATMENT OF METASTATIC CANCER
#1614SIRNA CONJUGATE AND PREPARATION METHOD THEREOF
#1615siRNA conjugate and preparation method thereof
#1616MicroRNA compounds and methods for modulating miR-122
#1617Methods and compositions involving miRNA and miRNA inhibitor molecules
#1618INHIBITION OF VIRAL GENE EXPRESSION
#1619Small interference RNAs, uses thereof and method for inhibiting the expression of plk1 gene
#1620CONTROLLING REGULATORY T CELL FUNCTION
#1621Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer
#1622Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity
#1623Methods and agents to increase therapeutic dystrophin expression in muscle
#1624Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA
#1625COMBINATORIAL METHODS AND COMPOSITIONS FOR TREATMENT OF MELANOMA
#1626RNAi for the control of insects and arachnids
#1627Gene expression and pain
#1628Oligonucleotides for RNA interference and biological applications thereof
#1629METHODS AND COMPOSITIONS FOR REDUCING ACTIVITY OF THE ATRIAL NATRIURETIC PEPTIDE RECEPTOR AND FOR TREATMENT OF DISEASES
#1630Methods of inhibiting Alu RNA and therapeutic uses thereof
#1631Micro-RNA scaffolds and non-naturally occurring micro-RNAs
#1632Compositions and methods for prognosis and treatment of prostate cancer
#1633Compositions and methods for modulating myeloid derived suppressor cells
#1634Modulation of signal transducer and activator of transcription 3 (STAT3) expression
#1635Therapeutic use of activators of zinc finger protein GL13
#1636Single-stranded nucleic acid molecule having amino acid backbone
#1637EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#1638COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#1639MITIGATION OF DISEASE BY INHIBITION OF GALECTIN-12
#1640METHOD FOR IMPROVING THE SUCCESS RATE OF HEMATOPOIETIC STEM CELL TRANSPLANTS
#1641Exon skipping compositions for treating muscular dystrophy
#1642Recombinant virus products and methods for inhibition of expression of DUX4
#1643Compositions for treating muscular dystrophy
#1644Methods and compositions involving miRNA and miRNA inhibitor molecules
#1645Induced pluripotent stem cells with synthetic modified RNAs
#1646Reduction of off-target RNA interference toxicity
#1647ANTISENSE OLIGONUCLEOTIDES AGAINST cPLA2, COMPOSITIONS AND USES THEREOF
#1648Inhibitors of metastasis
#1649METHODS OF MODULATING THE NEGATIVE CHEMOTAXIS OF IMMUNE CELLS
#1650PHOSPHOLIPID-DETERGENT CONJUGATES AND USES THEREOF
#1651NGF aptamer and application thereof
#1652Modulation of HSP47 expression
#1653Antisense modulation of PTP1B expression
#1654Methods for heart regeneration
#1655Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#1656MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS
#1657Control of gene expression
#1658Modified siRNA molecules and uses thereof
#1659Theranostic imaging agents and methods of use
#1660Nanotubes as carriers of nucleic acids into cells
#1661Methods for regulating neural differentiation
#1662Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression
#1663VEGF-D/VEGFR2/3-mediated regulation of dendrites
#1664Oligomeric compounds and compositions for use in modulation of small non-coding RNAS
#1665MiRNA for treating diseases and conditions associated with neo-angiogenesis
#1666Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#1667Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity
#1668Oligonucleotide compositions with enhanced efficiency
#1669Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
#1670Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL
#1671Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules
#1672Oligonucleotide analogues incorporating 5-aza-cytosine therein
#1673Method of deriving mature hepatocytes from human embryonic stem cells
#1674Method for producing novel hiPSC by means of miRNA introduction
#1675Method for producing novel hipsc by means of siRNA introduction
#1676Methods of generating oligodendrocytes and cell populations comprising same
#1677THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS
#1678Cationic lipid
#1679Oligomers
#1680Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#1681COMPOSITIONS AND METHODS RELATED TO MIRNA MODULATION OF NEOVASCULARIZATION OR ANGIOGENESIS
#1682Modified oligonucleotides for telomerase inhibition
#1683Mutator activity induced by microRNA-155 () links inflammation and cancer
#1684METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS
#1685Reduction of TGF beta signaling in myeloid cells in the treatment of cancer
#1686SDF-1 binding nucleic acids
#1687Modulation of Hepatitis B virus (HBV) expression
#1688MODULATION OF TIMP1 AND TIMP2 EXPRESSION
#1689Modulation of angiopoietin-like 3 expression
#1690Fidgetin-like 2 as a target to enhance wound healing
#1691iRNA Agents Targeting VEGF
#1692Compositions and methods for inhibiting expression of GSK-3 genes
#1693THERAPEUTIC AGENT FOR FIBROID LUNG
#1694Pharmaceutical Composition Comprising miRNA-100 And Its Use in the Modulation Of Blood Vessel Growth and Endothelial Inflammation
#1695Modified siRNA molecules and uses thereof
#1696Method of reducing recurrence of multiple sclerosis symptoms in a mammal by administering an anti-repulsive guidance molecule neutralizing antibody
#1697Methods for treating and/or limiting development of diabetes
#1698Modulation of synaptic maintenance
#1699Kits comprising linear DNAs for sustained polypeptide expression using synthetic, modified RNAs
#1700Kit for making induced pluripotent stem cells using modified RNAs
#1701Oral delivery of therapeutically effective LNA oligonucleotides
#1702MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS
#1703METHODS AND COMPOSITIONS FOR TREATING INSECTS
#1704MODULATION OF APOLIPOPROTEIN(A) EXPRESSION
#1705Low density lipoprotein receptor-mediated siRNA delivery
#1706Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products
#1707Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1
#1708VEGF-D/VEGFR2/3-MEDIATED REGULATION OF DENDRITES
#1709Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
#1710Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)
#1711Antisense modulation of PTP1B expression
#1712Structure and use of 5′ phosphate oligonucleotides
#1713Reduction of off-target RNA interference toxicity
#1714Method of inhibiting miR-33 using a modified oligonucleotide
#1715Antisense oligonucleotides against cPLA, compositions and uses thereof
#1716Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
#1717CONTROL OF GENE EXPRESSION
#1718Modulation of signal transducer and activator of transcription 3 (STAT3)expression
#1719Method of inducing an immune response
#1720Methods for treating chronic obstructive pulmonary disease
#1721OLIGOMERIC COMPOUNDS AND EXCIPIENTS
#1722Molecule for treating an inflammatory disorder
#1723Oligonucleotide complex compositions and methods of use as gene alteration tools
#1724TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A SIRTUIN (SIRT)
#1725RNA-INTERFERENCE BY SINGLE-STRANDED RNA MOLECULES
#1726RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
#1727Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF)
#1728Gene expression and pain
#1729Compositions and methods for prognosis and treatment of prostate cancer
#1730Treatment of vasculoproliferative conditions with Lrg1 anatgonists
#1731Compositions and methods for inhibiting expression of transthyretin
#1732Viral and viral associated mirnas and uses thereof
#1733ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis
#1734Molecules of the card-related protein family and uses thereof
#1735Cancer Specific Mitotic Network
#1736Modified L-Nucleic Acid
#1737Methods for Diagnosing Stomach Cancer Using MicroRNA Signatures
#1738Methods for Diagnosing Prostate Cancer Using MicroRNA Signatures
#1739Methods for diagnosing lung cancer using MicroRNA signatures
#1740Methods for diagnosing colon cancer using MicroRNA signatures
#1741Methods for Diagnosing Breast Cancer Using MicroRNA Signatures
#1742Methods for diagnosing stomach cancer using MicroRNAs
#1743Methods for diagnosing prostate cancer using MicroRNAs
#1744Methods for diagnosing pancreatic cancer using MicroRNAs
#1745Methods for diagnosing lung cancer using microRNAs
#1746Methods for diagnosing colon cancer using MicroRNAs
#1747Methods for diagnosing breast cancer using MicroRNAs
#1748Methods for diagnosing pancreatic cancer using miR-103-1, miR-103-2, miR-24-2 and miR-107
#1749Methods for Diagnosing Breast Cancer Using miR-21, miR-125-1, miR-125b-2 and miR-145
#1750Methods for Diagnosing Colon, Stomach, Prostate and Pancreas Cancer Using miR-223
#1751Methods for Diagnosing Breast and Lung Cancer Using miR-210 and miR-213
#1752Methods for diagnosing breast, colon, lung, pancreatic and prostate cancer using miR-21 and miR-17-5p
#1753Diagnostic and treatment for chronic and acute phase myeloid leukemia
#1754REPROGRAMMING COMPOSITIONS AND METHODS OF USING THE SAME
#1755DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
#1756Therapeutic and diagnostic molecules
#1757RNA WITH A COMBINATION OF UNMODIFIED AND MODIFIED NUCLEOTIDES FOR PROTEIN EXPRESSION
#1758Polynucleotides for multivalent RNA interference, compositions and methods of use thereof
#1759Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
#1760Compositions and methods for silencing apolipoprotein C-III expression
#1761Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#1762In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
#1763Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
#1764Further use of protein kinase N beta
#1765Chemical modification of short small hairpin RNAs for inhibition of gene expression
#1766Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
#1767Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
#1768Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1769Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
#1770Live attenuated influenza virus vaccines comprising microRNA response elements
#1771MODULATION OF TIMP1 AND TIMP2 EXPRESSION
#1772Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease
#1773Compositions and methods for treating cancer
#1774ANTISENSE OLIGONUCLEOTIDES (ODN) AGAINST SMAD7 AND USES THEREOF IN MEDICAL FIELD
#1775Embryonic stem cell specific microRNAs promote induced pluripotency
#1776MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION
#1777Treatment of Adiponectin related diseases by inhibition of natural antisense transcript to an Adiponectin
#1778RNA targeting in alpha-synucleinopathies
#1779Therapeutic nucleic acid-3′-conjugates
#1780Modified Small Interfering RNA Molecules and Methods of Use
#1781RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
#1782Targeting MicroRNAs for metabolic disorders
#1783Transcriptional repression leading to Parkinson's disease
#1784Methods for enhancing utrophin production via inhibition of microRNA
#1785Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1786siRNA conjugate and preparation method thereof
#1787Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2
#1788MicroRNAs and uses thereof
#1789Anti viral therapy
#1790Methods for treating hypercholesterolemia
#1791Method of diagnosing poor survival prognosis colon cancer using miR-29a
#1792Method of diagnosing poor survival prognosis colon cancer using miR-103-2
#1793TOPICAL THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES COMPRISING COMPOUND CAPABLE OF BINDING SPECIFICALLY TO DNA SEQUENCE
#1794Methods and compositions involving miRNA and miRNA inhibitor molecules
#1795MODULATING IRES-MEDIATED TRANSLATION
#1796Methods for regulating neural differentiation
#1797METHOD OF PREDICTING CHEMOTHERAPY EFFECTIVENESS IN COLON ADENOCARCINOMA PATIENTS, USING MIR-21
#1798Method of diagnosing poor survival prognosis colon cancer using miR-106a
#1799Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#1800DIFFERENTIATION THERAPY FOR SARCOMAS